Man Group’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,181
Closed -$271K 2070
2025
Q1
$271K Buy
+15,181
New +$271K ﹤0.01% 1735
2024
Q3
Sell
-300,171
Closed -$5.14M 1982
2024
Q2
$5.14M Sell
300,171
-243,653
-45% -$4.17M 0.01% 914
2024
Q1
$8.5M Buy
543,824
+386,436
+246% +$6.04M 0.02% 738
2023
Q4
$2.35M Buy
+157,388
New +$2.35M 0.01% 1133
2023
Q3
Sell
-99,857
Closed -$4.14M 1115
2023
Q2
$4.14M Buy
+99,857
New +$4.14M 0.01% 945
2023
Q1
Hold
0
874
2022
Q4
Sell
-2,990
Closed -$227K 2123
2022
Q3
$227K Buy
+2,990
New +$227K ﹤0.01% 1703
2022
Q2
Sell
-35,722
Closed -$2.96M 2170
2022
Q1
$2.96M Sell
35,722
-49,448
-58% -$4.1M 0.01% 1087
2021
Q4
$6.4M Sell
85,170
-2,916
-3% -$219K 0.02% 781
2021
Q3
$10.2M Buy
88,086
+45,727
+108% +$5.31M 0.04% 560
2021
Q2
$9.4M Buy
42,359
+1,077
+3% +$239K 0.03% 600
2021
Q1
$5.46M Buy
41,282
+4,275
+12% +$565K 0.02% 642
2020
Q4
$6.4M Sell
37,007
-32,282
-47% -$5.59M 0.03% 658
2020
Q3
$7.71M Buy
69,289
+10,415
+18% +$1.16M 0.03% 595
2020
Q2
$3.49M Buy
58,874
+33,437
+131% +$1.98M 0.02% 831
2020
Q1
$1.71M Sell
25,437
-10,949
-30% -$737K 0.01% 939
2019
Q4
$3.07M Buy
36,386
+26,086
+253% +$2.2M 0.01% 1174
2019
Q3
$770K Sell
10,300
-34,226
-77% -$2.56M ﹤0.01% 1488
2019
Q2
$2.82M Buy
44,526
+36,533
+457% +$2.31M 0.01% 1187
2019
Q1
$385K Sell
7,993
-5,991
-43% -$289K ﹤0.01% 1753
2018
Q4
$468K Sell
13,984
-156,772
-92% -$5.25M ﹤0.01% 1633
2018
Q3
$8.95M Buy
170,756
+22,631
+15% +$1.19M 0.03% 676
2018
Q2
$4.64M Buy
148,125
+6,208
+4% +$194K 0.02% 977
2018
Q1
$3.09M Buy
+141,917
New +$3.09M 0.01% 1077